Large pharma companies back appeal for TRIPS waiver for Covid-19 cure

“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time for solidarity and global cooperation,” Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance, told ET on Sunday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3lgcHoC
via IFTTT